OBJECTIVE: This study is to investigate anemia management trends in patients on peritoneal dialysis in Huashan Hospital in the past 10 years. METHODS: A total of 463 cases of patients receiving peritoneal dialysis from July 2004 to March 2014 were analyzed retrospectively. The patients enrolled in this study all were elder than 18 years old, those who had been followed up for at least 1 quarter. Clinical data of anemia including hemoglobin, serum iron, iron saturation, dosage of erythropoietin (EPO) and iron supplements were collected quarterly and then analyzed those data. RESULTS: In the first period of 25 quarters, in a certain range, increased dose of erythropoietin and iron content, can make the patient's hemoglobin gradually increased to the ideal level, which helps to treat the symptoms of anemia patients. Results of comparation before and after the education program showed that with the enhance the EPO injection compliance and treat anemia with the proper dose of EPO, the PD patients have stable level of Hemoglobin, accompanying with the decreased dose of oral Iron and intravenous iron. CONCLUSION: It was shown that hemoglobin value was constantly stable. Treat anemia with proper dose of EPO individually could cure anemia effectively with the reducing of iron supplement improvement peritoneal dialysis patients' anemia related knowledge, and the good compliance of injection of EPO, serum iron and iron saturation could still keep stable, although declined intake of iron supplements. Therefore, optimizing anemia management in peritoneal dialysis patients is helpful to improve their quality of life.
OBJECTIVE: This study is to investigate anemia management trends in patients on peritoneal dialysis in Huashan Hospital in the past 10 years. METHODS: A total of 463 cases of patients receiving peritoneal dialysis from July 2004 to March 2014 were analyzed retrospectively. The patients enrolled in this study all were elder than 18 years old, those who had been followed up for at least 1 quarter. Clinical data of anemia including hemoglobin, serum iron, iron saturation, dosage of erythropoietin (EPO) and iron supplements were collected quarterly and then analyzed those data. RESULTS: In the first period of 25 quarters, in a certain range, increased dose of erythropoietin and iron content, can make the patient's hemoglobin gradually increased to the ideal level, which helps to treat the symptoms of anemiapatients. Results of comparation before and after the education program showed that with the enhance the EPO injection compliance and treat anemia with the proper dose of EPO, the PDpatients have stable level of Hemoglobin, accompanying with the decreased dose of oral Iron and intravenous iron. CONCLUSION: It was shown that hemoglobin value was constantly stable. Treat anemia with proper dose of EPO individually could cure anemia effectively with the reducing of iron supplement improvement peritoneal dialysis patients' anemia related knowledge, and the good compliance of injection of EPO, serum iron and iron saturation could still keep stable, although declined intake of iron supplements. Therefore, optimizing anemia management in peritoneal dialysis patients is helpful to improve their quality of life.
Authors: Francesco Locatelli; Pedro Aljama; Bernard Canaud; Adrian Covic; Angel De Francisco; Iain C Macdougall; Andrzej Wiecek; Raymond Vanholder Journal: Nephrol Dial Transplant Date: 2010-06-29 Impact factor: 5.992
Authors: Francesco Locatelli; Ronald L Pisoni; Christian Combe; Juergen Bommer; Vittorio E Andreucci; Luis Piera; Roger Greenwood; Harold I Feldman; Friedrich K Port; Philip J Held Journal: Nephrol Dial Transplant Date: 2004-01 Impact factor: 5.992
Authors: Harmeet Singh; John Reed; Sylvia Noble; Jose L Cangiano; David B Van Wyck Journal: Clin J Am Soc Nephrol Date: 2006-03-29 Impact factor: 8.237
Authors: Ronald L Pisoni; Jennifer L Bragg-Gresham; Eric W Young; Tadao Akizawa; Yasushi Asano; Francesco Locatelli; Juergen Bommer; Jose Miguel Cruz; Peter G Kerr; David C Mendelssohn; Philip J Held; Friedrich K Port Journal: Am J Kidney Dis Date: 2004-07 Impact factor: 8.860
Authors: Jose Portolés-Pérez; Beatriz Durá-Gúrpide; José Luis Merino-Rivas; Leyre Martín-Rodriguez; Covadonga Hevia-Ojanguren; Victor Burguera-Vion; Claudia Yuste-Lozano; Luisa Sánchez-García; Jose Ramon Rodriguez-Palomares; Vicente Paraiso Journal: Clin Kidney J Date: 2019-11-22